Who owns HCW BIOLOGICS INC?
- Ticker: HCWB
- CUSIP Number: 40423r105
Tip: Access positions for across all investors
Analyze quarterly positions in Hcw Biologics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Hcw Biologics stock
Who bought or sold HCW BIOLOGICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
HighTower Advisors | 180k | $316k | 0% | Mar 2024 |
|
Honkamp Krueger Financial Services | 180k | $315k | 0% | Mar 2024 |
|
Geode Capital Management | 174k | $291k | 32% | Mar 2024 |
|
Pullen Investment Management | 85k | $149k | 100% | Mar 2024 |
|
Bridgeway Capital Management | 85k | $141k | 3% | Mar 2024 |
|
Hrt Financial | 73k | $122k | 100% | Mar 2024 |
|
BlackRock | 46k | $81k | -4% | Mar 2024 |
|
Vanguard Group | 38k | $66k | -82% | Mar 2024 |
|
AE Wealth Management | 30k | $53k | 0% | Mar 2024 |
|
Two Sigma Investments | 23k | $40k | 0% | Mar 2024 |
|
Jane Street | 17k | $30k | 100% | Mar 2024 |
|
Northern Trust | 10k | $18k | 0% | Mar 2024 |
|
Tower Research Capital | 4.9k | $8.6k | 6% | Mar 2024 |
|
UBS Group | 605.00 | $1.1k | -5% | Mar 2024 |
|
Bank of America Corporation | 406.00 | $710.012800 | 3591% | Mar 2024 |
|
Royal Bank of Canada | 244.00 | $0 | -18% | Mar 2024 |
|
Wells Fargo & Company | 141.00 | $247.003800 | 2% | Mar 2024 |
|
Jpmorgan Chase & Co | 9.00 | $15.000300 | -89% | Mar 2024 |
|
Who sold out of Hcw Biologics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Citadel Advisors | Dec 2023 | 10k | $13k |
Focused Wealth Management | Dec 2023 | 1.0k | $1.2k |